Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guilubusen is a traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Guangdong Xinbao Pharmaceutical. It is primarily indicated for "tonifying the kidney" and strengthening the body, addressing symptoms associated with kidney deficiency such as general weakness, dizziness, fatigue, and lower back pain. The formulation's name is derived from its key traditional ingredients: tortoise shell (Gui Ban) and deer antler glue (Lu Rong Jiao), which are traditionally used to nourish yin and tonify yang. It is administered orally as a tablet and is approved for use in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on guilubusen.